Professor | Rongquan Xiao | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Rongquan Xiao
Contact Information	xiaorq@sustech.edu.cn
Language ability	Chinese, English
Province	Guangdong

Upload Avatar (500 x 500)

Name

Rongquan Xiao

Contact Information

xiaorq@sustech.edu.cn

Language ability

Chinese, English

Province

Guangdong

University/Lab Affiliation and Title	Southern University of Science and Technology
Faculty	Medical School
Academic Background & Achievements	2014/09 - 2020/06 PhD in Chemical Biology: Xiamen University 2020 PhD, supervised by Professor Liu Wen
Work Experience	2023/06 - Present: Southern University of Science and Technology, Medical School, Research Assistant Professor 2020/07 - 2023/06: Xiamen University, School of Pharmacy, Postdoctoral Researcher
Awards	Xiamen University Life Sciences and Human Health Group 2021 Outstanding Postdoctoral Support, 2021 Xiamen University 'Outstanding Graduate' honor, 2020 Xiamen University School of Pharmacy 'Zhuang Jin Scholarship' Outstanding Contribution Award, 2018

University/Lab Affiliation and Title

Southern University of Science and Technology

Faculty

Medical School

Academic Background & Achievements

2014/09 - 2020/06 PhD in Chemical Biology: Xiamen University
2020 PhD, supervised by Professor Liu Wen

Work Experience

2023/06 - Present: Southern University of Science and Technology, Medical School, Research Assistant Professor
2020/07 - 2023/06: Xiamen University, School of Pharmacy, Postdoctoral Researcher

Awards

Xiamen University Life Sciences and Human Health Group 2021 Outstanding Postdoctoral Support, 2021
Xiamen University 'Outstanding Graduate' honor, 2020
Xiamen University School of Pharmacy 'Zhuang Jin Scholarship' Outstanding Contribution Award, 2018

Areas of Focus	Epigenetic regulatory factors in tumors: function, molecular mechanisms, and applications
Publications	A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo, Xiao RQ, Ran T, Huang QX, Hu GS, Fan DM, Yi J, Liu W, 2022 JMJD6 licenses estrogen receptor a-dependent enhancer and coding gene activation by modulating the recruitment of the CARM1/MED12 co-activator complex, Gao WW, Xiao RQ, Zhang WG, Hu YR, Peng BL, Li WJ, He YH, Shen HF, Ding JC, Huang QX, Ye TY, Li Y, Liu ZY, Ding R, Rosenfeld MG, Liu W, 2018 In Silico Discovery of JMJD6 Inhibitors for Cancer Treatment, Ran T, Xiao RQ, Huang QX, Yuan HL, Lu T, Liu W, 2019 Arginine methylation of HSP70 regulates retinoid acid-mediated RARβ2 gene activation, Gao WW, Xiao RQ, Peng BL, Xu HT, Shen HF, Huang MF, Shi TT, Yi J, Zhang WJ, Wu XN, Gao X, Lin XZ, Dorrestein PC, Rosenfeld MG, Liu W, 2015 ER-localized JmjC domain-containing protein JMJD8 targets STING to promote immune evasion and tumor growth in breast cancer, Yi J, Wang L, Du J, Wang MY, Shen HF, Liu ZY, Qin Y, Liu J, Hu GS, Xiao RQ, Ding JC, Chen HJ, Wang HJ, Huang HH, Ouyang GL, Liu W, 2023 A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor a-dependent transcriptional activation and breast carcinogenesis, Peng BL, Li WJ, Ding JC, He YH, Ran T, Xie BL, Wang ZR, Shen HF, Xiao RQ, Gao WW, Ye TY, Gao X, Liu W, 2020 Regulation of Transcription Factor Yin Yang 1 by SET7/9-mediated Lysine Methylation, Zhang WJ, Wu XN, Shi TT, Xu HT, Yi J, Shen HF, Huang MF, Su XY, Wang FF, Peng BL, Xiao RQ, Gao WW, Ding JC, Liu W, 2016 Patient-derived xenografts (PDX) identify JMJD6 inhibitor as an effective therapeutic medicine in colorectal cancer, Ye F, You J, Xia L, Lian JB, Xiao RQ, Ran T, Gao X, Li JY, Zhao X, Gao J, Lin HX, Zheng JN, Liu W, 2019

Areas of Focus

Epigenetic regulatory factors in tumors: function, molecular mechanisms, and applications

Publications

A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo, Xiao RQ, Ran T, Huang QX, Hu GS, Fan DM, Yi J, Liu W, 2022
JMJD6 licenses estrogen receptor a-dependent enhancer and coding gene activation by modulating the recruitment of the CARM1/MED12 co-activator complex, Gao WW, Xiao RQ, Zhang WG, Hu YR, Peng BL, Li WJ, He YH, Shen HF, Ding JC, Huang QX, Ye TY, Li Y, Liu ZY, Ding R, Rosenfeld MG, Liu W, 2018
In Silico Discovery of JMJD6 Inhibitors for Cancer Treatment, Ran T, Xiao RQ, Huang QX, Yuan HL, Lu T, Liu W, 2019
Arginine methylation of HSP70 regulates retinoid acid-mediated RARβ2 gene activation, Gao WW, Xiao RQ, Peng BL, Xu HT, Shen HF, Huang MF, Shi TT, Yi J, Zhang WJ, Wu XN, Gao X, Lin XZ, Dorrestein PC, Rosenfeld MG, Liu W, 2015
ER-localized JmjC domain-containing protein JMJD8 targets STING to promote immune evasion and tumor growth in breast cancer, Yi J, Wang L, Du J, Wang MY, Shen HF, Liu ZY, Qin Y, Liu J, Hu GS, Xiao RQ, Ding JC, Chen HJ, Wang HJ, Huang HH, Ouyang GL, Liu W, 2023
A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor a-dependent transcriptional activation and breast carcinogenesis, Peng BL, Li WJ, Ding JC, He YH, Ran T, Xie BL, Wang ZR, Shen HF, Xiao RQ, Gao WW, Ye TY, Gao X, Liu W, 2020
Regulation of Transcription Factor Yin Yang 1 by SET7/9-mediated Lysine Methylation, Zhang WJ, Wu XN, Shi TT, Xu HT, Yi J, Shen HF, Huang MF, Su XY, Wang FF, Peng BL, Xiao RQ, Gao WW, Ding JC, Liu W, 2016
Patient-derived xenografts (PDX) identify JMJD6 inhibitor as an effective therapeutic medicine in colorectal cancer, Ye F, You J, Xia L, Lian JB, Xiao RQ, Ran T, Gao X, Li JY, Zhao X, Gao J, Lin HX, Zheng JN, Liu W, 2019

Epigenetics Tumors Molecular Mechanisms Cancer Research Gene Regulation Biological Applications Disease Mechanisms Therapeutic Targets Molecular Biology Cellular Processes

Xueping Qiu - Wuhan University

Min Zhao - Wuhan University

Yunfei Hu - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us